Integrative Multi-Omics Analysis Suggests a Proteostasis-Translation-Neuroimmune Axis Underlying Moxifloxacin Associated Cognitive Impairment
Abstract
Moxifloxacin, a widely used fluoroquinolone antibiotic, has been associated with cognitive impairment, but its molecular mechanisms remain unclear. Here, we applied an integrative multi-omics approach combining network toxicology, transcriptomics, molecular docking, molecular dynamics simulation, and Mendelian randomization to investigate potential mechanisms. We identified 85 overlapping targets linking moxifloxacin to cognitive dysfunction, with HSP90AB1 emerging as a central hub. Molecular docking and molecular dynamics simulations suggested a potential interaction between moxifloxacin and HSP90AB1, which was further supported by biolayer interferometry, yielding an apparent KD of 1.044 ± 0.053 μM. Transcriptomic and enrichment analyses highlighted translation-related pathways and neuroimmune-related signaling, while summary-data-based Mendelian randomization (SMR) analysis implicated APP as a genetically supported candidate component. Experimental validation in BV2 microglial cells showed a reduction in APP protein abundance without a corresponding decrease in APP mRNA, whereas SH-SY5Y cells exhibited a distinct concentration-dependent response. Together, our findings suggest that moxifloxacin-associated cognitive impairment may involve a proteostasis-translation-related-neuroimmune framework, with HSP90AB1 and APP representing candidate molecular components. This study provides a mechanistic framework for fluoroquinolone neurotoxicity and identifies candidate targets…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.